Foot Locker's Q4 Beats Expectations Penske Renews With Logano, Shell-Pennzoil Pimlico Report Calls For $300M Renovation MTS Centre Getting C$12M In Upgrades Crew Unveil New Gold Uniforms NASCAR Hopes Format Captures New Fans Alabama Football Program Nets $47M-Plus Profit MLB Giants Payroll To Top $200M For First Time As Top Stars Retire, Young Drivers Carry Hope FS1 Developing New TV Shows For Katie Nolan
SBD/9/Sponsorships Advertising Marketing
BREATHE RIGHT CRUISES THROUGH FDA APPROVAL TO ADVERTISE
Published November 9, 1995
The FDA said Wednesday that CNS Inc. can advertise Breathe Right to chronic snorers, following an announcement Monday the company's patent application should be approved "within weeks," according to USA TODAY. Although CNS received FDA approval to sell the strips in '93, the company has been forbidden to advertise them. Del Jones of USA TODAY notes "most people know of" the product from watching football. CNS revenue grew from $2.8M in '94 to $36.5M in the first nine months of this year, but CEO Dan Cohen says the product "isn't a fad." He points out that only 10% of the strips are sold to athletes (USA TODAY, 11/9).